Showing results 5 to 24 of 25
< previous
next >
Preview | Issue Date | Title | Author(s) |
| 1999 | C160rf5, a novel proline-rich gene at 16p13.3, is highly expressed in the brain | Bhalla, K.; Eyre, H.; Whitmore, S.; Sutherland, G.; Callen, D. |
| 2002 | CBFA2T3 (MTG16) is a putative breast tumor suppressor gene from the breast cancer loss of heterozygosity region at 16q24.3 | Kochetkova, M.; McKenzie, O.; Bais, A.; Martin, J.; Secker, G.; Seshadri, R.; Powell, J.; Hinze, S.; Gardner, A.; Spendlove, H.; O'Callaghan, N.; Cleton-Jansen, A.; Cornelisse, C.; Whitmore, S.; Crawford, J.; Kremmidiotis, G.; Sutherland, G.; Callen, D. |
| 1999 | Characterization of copine VII, a new member of the copine family, and its exclusion as a candidate in sporadic breast cancers with loss of heterozygosity at 16q24.3 | Savino, M.; d'Apolito, M.; Centra, M.; van Beerendonk, H.; Cleton-Jansen, A.M.; Whitmore, S.; Crawford, J.; Callen, D.; Zelante, L.; Savoia, A. |
| 1998 | Construction of a high-resolution physical and transcription map of chromosome 16q24.3 - a region of frequent loss of heterozygosity in sporadic breast cancer | Whitmore, S.; Crawford, J.; Apostolou, S.; Eyre, H.; Baker, E.; Lower, K.; Settasatian, C.; Goldup, S.; Seshadri, R.; Gibson, R.; Mathew, C.; Cleton-Jansen, A.M.; Savoia, A.; Pronk, J.; Auerbach, A.; Doggett, N.; Sutherland, G.; Callen, D. |
| 2002 | Defining regions of loss of heterozygosity of 16q in breast cancer cell lines | Callen, D.; Crawford, J.; Derwas, C.; Cleton-Jansen, A.; Cornelisse, C.; Baker, E. |
| 2005 | FBXO31 is the chromosome 16q24.3 senescence gene, a candidate breast tumor suppressor, and a component of an SCF complex | Kumar, R.; Neilsen, P.; Crawford, J.; McKirdy, R.; Lee, J.; Powell, J.; Saif, Z.; Martin, J.; Lombaerts, M.; Cornelisse, C.; Cleton-Jansen, A.; Callen, D. |
| 1997 | Genomic structure and complete nucleotide sequence of the Batten Disease Gene, CLN3 | Mitchison, H.; Munroe, P.; O'Rawe, A.; Taschner, P.; De Vos, N.; Kremmidiotis, G.; Lensink, I.; Munk, A.; D'Arigo, K.; Anderson, J.; Lerner, T.; Moyzis, R.; Callen, D.; Breuning, M.; Doggett, N.; Gardiner, R.; Mole, S. |
| 1997 | High resolution characterisation of an interstitial deletion of less than 1.9Mb at 4p16.3 associated with Wolf-Hirschhorn Syndrome | Fang, Y.; Bain, S.; Haan, E.; Eyre, H.; MacDonald, M.; Wright, T.; Altherr, M.; Riess, O.; Sutherland, G.; Callen, D. |
| 2011 | Inherited Balanced Translocation t(9;17)(q33.2;q25.3) Concomitant With a 16p13.1 Duplication in a Patient With Schizophrenia | Fullston, T.; Gabb, B.; Callen, D.; Ullmann, R.; Woollatt, E.; Bain, S.; Ropers, H.; Cooper, M.; Chandler, D.; Carter, K.; Jablensky, A.; Kalaydjieva, L.; Gecz, J. |
| 1995 | Integration of transcript and genetic maps of chromosome 16 at near-1-Mb resolution: demonstration of a 'hot-spot' for recombination at 16p12 | Callen, D.; Lane, S.; Kozman, H.; Kremmidiotis, G.; Whitmore, S.; Lowenstein, M.; Doggett, N.; Kenmochi, N.; Page, D.; Maglott, D.; Nierman, W.; Murakawa, K.; Sikela, J.; Houlgatte, R.; Auffray, C.; Sutherland, G. |
| 1995 | Localization of the gene for human 11b hydroxysteroid dehydrogenase type 2 enzyme to chromosome 16q22 | Krozowski, Z.; Baker, E.; Obeyesekere, V.; Callen, D. |
| 1995 | Mechanisms of small ring formation suggested by the molecular characterization of 2 small accessory ring chromosomes derived from chromosome 4 | Fang, Y.; Eyre, H.; Bohlander, S.; Estop, A.; McPherson, E.; Trager, T.; Riess, O.; Callen, D. |
| 1996 | Molecular cloning of the cDNA and chromosome localization of the gene for human ubiquitin-conjugating enzyme 9 | Wang, Z.; Qiu, Q.; Seufert, W.; Taguchi, T.; Testa, J.; Whitmore, S.; Callen, D.; Welsh, D.; Shenk, T.; Deuel, T. |
| 1999 | Origins of accessory small ring marker chromosomes derived from chromosome 1 | Callen, D.; Eyre, H.; Fang, Y.; Guan, X.; Veleba, A.; Martin, N.; McGill, J.; Haan, E. |
| 1995 | Paracentric inversions do not normally generate monocentric recombinant chromosomes | Sutherland, G.; Callen, D.; McKinlay Gardner, R. |
| 1996 | Positional cloning of the Fanconi anaemia group A gene | Apostolou, S.; Whitmore, S.; Crawford, J.; Lennon, G.; Sutherland, G.; Callen, D.; Ianzano, L.; Savino, M.; d'Apolito, M.; Notarangelo, A.; Memeo, E.; Piemontese, M.; Zelante, L.; Savoia, A.; Gibson, R.; Tipping, A.; Morgan, N.; Hassock, S.; Jansen, S.; de Ravel, T.; et al. |
| 2002 | Sequencing, transcript identification, and quantitative gene expression profiling in the breast cancer loss of heterozygosity region 16q24.3 reveal three potential tumor-suppressor genes | Powell, J.; Gardner, A.; Bais, A.; Hinze, S.; Baker, E.; Whitmore, S.; Crawford, J.; Kochetkova, M.; Spendlove, H.; Doggett, N.; Sutherland, G.; Callen, D.; Kremmidiotis, G. |
| 2002 | Study of 250 children with idiopathic mental retardation reveals nine cryptic and diverse subtelomeric chromosome anomalies | Baker, E.; Hinton, L.; Callen, D.; Altree, M.; Dobbie, A.; Eyre, H.; Sutherland, G.; Thompson, E.; Thompson, P.; Woollatt, E.; Haan, E. |
| 1999 | The Batten disease gene product (CLN3p) is a Golgi integral membrane protein | Kremmidiotis, G.; Lensink, I.; Bilton, R.; Woollatt, E.; Chataway, T.; Sutherland, G.; Callen, D. |
| 2002 | Tumour Suppressor Gene | Callen, D.; Whitmore, S.; Kremmidiotis, G.; Kochetkova, M.; Crawford, J.; Griffith Hack; Bionomics Ltd |